Westside Investment Management’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-51
Closed 849
2022
Q4
$0 Hold
51
﹤0.01% 834
2022
Q3
$0 Hold
51
﹤0.01% 838
2022
Q2
$2 Hold
51
﹤0.01% 760
2022
Q1
$3 Buy
+51
New +$4.55K ﹤0.01% 726
2021
Q1
Sell
-75
Closed -$2.79K 738
2020
Q4
$2.79K Hold
75
0.01% 162
2020
Q3
$2.71K Buy
+75
New +$9.14K ﹤0.01% 170

Other funds holding NVAX

Westside Investment Management's NVAX Position: Q1 2023 in Review

Westside Investment Management sold out of Novavax (NVAX) in Q1 2023, closing a stake of 51 shares.

Westside Investment Management first reported a position in NVAX in Q3 2020 and held it in 6 quarters. The position peaked at $2.79K in Q4 2020. 222 funds tracked by Wall St. Rank hold NVAX as of Q1 2023.

  • Westside Investment Management reported no remaining Novavax position as of Q1 2023 after selling out during the quarter.
  • Westside Investment Management sold 51 Novavax shares in Q1 2023.
  • Westside Investment Management first reported a position in Novavax in Q3 2020 and held it in 6 quarters.
  • Westside Investment Management's Novavax position peaked at $2.79K in Q4 2020.
  • 222 funds tracked by Wall St. Rank held Novavax as of Q1 2023.

Based on Westside Investment Management's 13F filing for Q1 2023, filed 17 May 2023.